“Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer” (2020) Farmeconomia. Health economics and therapeutic pathways, 21(1). doi:10.7175/fe.v21i1.1450.